文献速递心外重症与机械循环支持

新分配系统下ECMO桥接心脏移植患者生存改善

Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system.
PubMed 文献 · J Heart Lung Transplant · 2020-11-09

该研究比较了新、旧心脏移植分配系统下ECMO支持患者的等待名单和移植后结局。新系统下患者移植累积发生率更高、死亡或移除率更低,移植后6个月生存率从旧系统的74.6%提高至90.6%。

要点

  • 新分配系统下ECMO桥接患者移植等待时间更短、移植率更高。
  • 新系统下移植后6个月生存率90.6%,显著优于旧系统74.6%。
  • 新系统下ECMO支持患者等待名单死亡或移除风险更低。

核心结论

  • 实施新心脏移植分配系统后,ECMO支持患者等待时间更短、移植频率更高、移植后短期生存改善。

主要发现

  • 新系统列名患者移植累积发生率更高(p < 0.001),从移植名单死亡或移除的发生率更低(p = 0.001)。
  • 移植后6个月生存率旧系统为74.6%,新系统为90.6%(p = 0.002)。
  • 在新系统列名或移植与等待名单和移植后结局改善独立相关。

临床怎么用

  • 新分配系统下ECMO桥接心脏移植的短期生存改善,支持对合适患者积极应用ECMO桥接策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Historically, patients bridged on extracorporeal membrane oxygenation (ECMO) to heart transplantation (HT) have very high post-transplant mortality. In the new heart transplant allocation system, ECMO-supported patients have the highest priority for HT. However, data are lacking on the outcomes of these critically ill patients. We compared the waitlist and post-transplant outcomes of ECMO-supported patients in the new and old allocation systems. METHODS: Adult patients supported by ECMO at the time of listing or transplantation who were registered in the United Network for Organ Sharing database between November 1, 2015 and September 30, 2019 were included. Clinical characteristics, outcomes in the waitlist, and post-transplant survival were compared between the old and new systems. Cox Proportional and subdistribution hazard regression models were used to evaluate the variables contributing to the post-transplant and waitlist outcomes RESULTS: A total of 296 ECMO-supported patients were listed for HT. Of these, 191 were distributed to the old system, and 105 were distributed to the new system. Patients listed in the new system had a higher cumulative incidence of HT (p < 0.001) and lower incidence of death or removal (p = 0.001) from the transplant list than patients listed in the old system. The 6-month survival after transplantation was 74.6% and 90.6% for the old- and new-era patients, respectively (p = 0.002). Among ECMO-supported patients, being listed or transplanted on the new system was independently associated with improved outcomes in the waitlist and after transplantation. CONCLUSIONS: With the implementation of the new heart transplant allocation system, ECMO-supported patients have a shorter waitlist time, improved frequency of HT, and improved short-term post-transplant survival.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Gonzalez MH, Acharya D, Lee S, et al. Improved survival after heart transplantation in patients bridged with extracorporeal membrane oxygenation in the new allocation system. J Heart Lung Transplant. 2020. PMID: 33277169. doi:10.1016/j.healun.2020.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。